A NOVEL TUMOR ANTIGEN AND FOXP3 DUAL TARGETING TUMOR CELL VACCINE ENHANCES THE IMMUNOTHERAPY IN A MURINE MODEL OF RENAL CELL CARCINOMA

$370,143FY2013Department of DefenseDOD

Health Research, Inc., Rockville MD

Investigators